(Q46454512)

22 December 2017

title

The efficacy and safety of thymosin alpha-1 in Japanese patients with chronic hepatitis B; results from a randomized clinical trial (English)

1 reference

22 December 2017

1 reference

1 reference

8

1 reference

22 December 2017

author name string

S Iino

1

1 reference

22 December 2017

J Toyota

2

1 reference

22 December 2017

H Kumada

3

1 reference

22 December 2017

K Kiyosawa

4

1 reference

22 December 2017

S Kakumu

5

1 reference

22 December 2017

M Sata

6

1 reference

22 December 2017

H Suzuki

7

1 reference

22 December 2017

publication date

1 May 2005

1 reference

22 December 2017

Journal of Viral Hepatitis

published in

1 reference

22 December 2017

volume

12

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

300-306

1 reference

22 December 2017

Management of chronic hepatitis B.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Therapy of chronic hepatitis B: current challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Thymalfasin for the treatment of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Thymosin-alpha1 regulates MHC class I expression in FRTL-5 cells at transcriptional level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Randomized, controlled trial of natural interferon-alpha therapy for e-antigen-positive chronic hepatitis B patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Results of lamivudine trials in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00633.X

10.1111/J.1365-2893.2005.00633.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017